Allergan plc (NYSE:AGN)

188.34
Delayed Data
As of Dec 13
 +0.07 / +0.04%
Today’s Change
114.27
Today|||52-Week Range
190.41
+40.91%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Quarter 2
2019
Revenue and IncomeNet Revenues3.9B4.1B3.6B4.1B
 
 
 
 
 
Cost of Goods Sold534.4M534.2M428.1M577.3M
 
 
 
 
 
Depreciation And Amortization1.6B1.6B1.4B1.5B
 
 
 
 
 
 
Operating ExpensesGross Income1.7B1.9B1.7B2.1B
 
 
 
 
 
General Expenses1.5B1.8B1.5B1.6B
 
 
 
 
 
Research And Development445.6M674.5M432.0M447.7M
 
 
 
 
 
Total Operating Expenses3.6B4.0B3.4B3.6B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income268.7M116.5M224.1M474.5M
 
 
 
 
 
Extraordinary Credit21.4M14.8M10.4M100.0K
 
 
 
 
 
Extraordinary Charge-41.3M-2.9B-2.5B-1.6B
 
 
 
 
 
Interest Expense On Debt220.4M210.2M201.8M195.4M
 
 
 
 
 
Other Expenses138.7M-2.6B2.1M-137.5M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income177.1M-5.6B-2.5B-1.5B
 
 
 
 
 
Income Taxes-213.4M-1.3B-68.6M-301.6M
 
 
 
 
 
Minority Interest-1.6M-4.0M-700.0K-4.1M
 
 
 
 
 
Net Income-37.9M-4.3B-2.4B-1.8B
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS339.0M335.1M332.0M327.8M
 
 
 
 
 
Shares To Calculate EPS Diluted339.0M335.1M332.0M327.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.11-$12.83-$7.25-$5.37
 
 
 
 
 
EPS Diluted-$0.11-$12.83-$7.25-$5.37